The effects of zolpidem treatment on GABA A receptors in cultured cerebellar granule cells: Changes in functional coupling

Life Sciences

Volumn 90, Issue 23-24, 2012, Pages 889-894

  Vlainić, Josipa ^a   Štrac, Dubravka Švob ^a   Jembrek, Maja Jazvinšćak ^a   Vlainić, Toni ^a   Peričić, Danka ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

3H flunitrazepam binding; Cerebellar granule cells; GABA A receptor; Gene expression; Tolerance; Zolpidem

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE; FLUNITRAZEPAM; ZOLPIDEM;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CEREBELLUM; COMPLEX FORMATION; CONTROLLED STUDY; DRUG BINDING SITE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; GRANULE CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CELL MEMBRANE; CELLS, CULTURED; CEREBELLUM; DRUG TOLERANCE; FLUNITRAZEPAM; GABA-A RECEPTOR AGONISTS; HYPNOTICS AND SEDATIVES; POLYMERASE CHAIN REACTION; PYRIDINES; RATS; RECEPTORS, GABA-A;

RATTUS;

EID: 84862022614     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.04.021     Document Type: Article

References (47)

1. Ali NJ, Olsen RW. Chronic benzodiazepine treatment of cells expressing recombinant GABA(A) receptors uncouples allosteric binding: studies on possible mechanisms. J Neurochem 2001;79:1100-8. (Pubitemid 33117091)
2. Arbilla S, Depoortere H, George P, Langer SZ. Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats. Naunyn Schmiedebergs Arch Pharmacol 1985;330:248-51. (Pubitemid 15003586)
3. Auta J, Impagnatiello F, Kadriu B, Guidotti A, Costa E. Imidazenil: a low efficacy agonist at alpha1- but high efficacy at alpha5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem. Neuropharmacology 2008;55:148-53.
4. Bateson AN. Basic pharmacological mechanisms involved in benzodiazepine tolerance and withdrawal. Curr Pharm Des 2002;8:5-21. (Pubitemid 34449900)
5. Birnir B, Korpi ER. The impact of sub-cellular location and intracellular neuronal proteins on properties of GABA(A) receptors. Curr Pharm Des 2007;13:3169-77. (Pubitemid 350201693)
6. Bovolin P, Santi MR, Puia G, Costa E, Grayson D. Expression patterns of gamma-aminobutyric acid type A receptor subunit mRNAs in primary cultures of granule neurons and astrocytes from neonatal rat cerebella. Proc Natl Acad Sci 1992;89:9344-8.
7. Brown MJ, Wood MD, Coldwell MC, Bristow DR. γ-Aminobutyric acidA receptor function is desensitized in rat cultured cerebellar granule cells following chronic flunitrazepam treatment. J Neurochem 1998;71:1232-40. (Pubitemid 28390278)
8. Buhr A, Sigel E. A point mutation in the gamma2 subunit of gamma-aminobutyric acid type A receptors results in altered benzodiazepine binding site specificity. Proc Natl Acad Sci U S A 1997;94:8824-9. (Pubitemid 27335124)
9. A receptor and docking studies with zolpidem: implications for selectivity. J Mol Graph Model 2007;26:537-45.
10. A receptor gamma2 subunit. Neuropharmacology 2004;4:17-34.
11. Costa E, Guidotti A. Benzodiazepines on trial: a research strategy for their rehabilitation. Trends Pharmacol Sci 1996;71:1232-40.
12. Crestani F, Martin JR, Mohler H, Rudolph U. Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol 2000;131:1251-4.
13. DeBlasi A, O'Reilly K, Motulsky HJ. Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol Sci 1989;10:227-9. (Pubitemid 19146394)
14. Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, et al. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther 1986;237:649-58. (Pubitemid 16092830)
15. Follesa P, Mancuso L, Biggio F, Cagetti E, Franco M, Trapani G, et al. Changes in GABA(A) receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem. Neuropharmacology 2002;42:191-8. (Pubitemid 34137022)
16. Friedman LK, Gibbs TT, Farb DH. gamma-aminobutyric acidA receptor regulation: heterologous uncoupling ofmodulatory site interactions induced by chronic steroid, barbiturate, benzodiazepine, or GABA treatment in culture. Brain Res 1996;707:100-9.
17. Gallager DW, Lakoski JM, Gonsalves SF, Rauch SL. Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity. Nature 1984;308:74-7. (Pubitemid 14130936)
18. Holt RA, Bateson AN, Martin IL. Chronic zolpidem treatment alters GABA(A) receptor mRNA levels in the rat cortex. Eur J Pharmacol 1997;329:129-32.
19. Hu XJ, TickuMK. Chronic benzodiazepine agonist treatment reduces functional uncoupling of the recombinant of the γ-aminobutyric acid-benzodiazepine receptor ionophore complex in cortical neurons. Mol Pharmacol 1994;45:618-25. (Pubitemid 24139188)
20. Jazvinšćak Jembrek M, Švob Štrac D, Vlainić J, Peričić D. The role of transcriptional and translational mechanisms in flumazenil-induced up-regulation of recombinant GABA(A) receptors. Neurosci Res 2008;61:234-41.
21. A receptors expressed in stably transfected cells. J Neurochem 1994;63:2349-52.
22. A and benzodiazepine agonists. J Pharmacol Exp Ther 1995;274:1484-92.
23. Korpi ER, Grunder G, Lüddens H. Drug interactions at GABA(A) receptors. Prog Neurobiol 2002;67:113-59.
24. A receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci 1992;12:4151-72.
25. A receptor benzodiazepine binding pocket mediate benzodiazepine efficacy and binding. Mol Pharmacol 2011;80:14-22.
26. Oberdoerster J, Rabin RA. Enhanced caspase activity during ethanol-induced apoptosis in rat cerebellar granule cells. Eur J Pharmacol 1999;385:273-82.
27. Olsen RW, Sieghart W. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Pharmacol Rev 2008;60:243-60.
28. Peričić D, Lazić J, Jazvinšćak JembrekM, Švob Štrac D, Rajčan I. Chronic exposure of cells expressing recombinant GABAA receptors to benzodiazepine antagonist flumazenil enhances themaximum number of benzodiazepine binding sites. Life Sci 2004;76:303-17. (Pubitemid 39452912)
29. Peričić D, Jazvinšćak Jembrek M, Švob Štrac D, Lazić J, Špoljarić IR. Enhancement of benzodiazepine binding sites following chronic treatment with flumazenil. Eur J Pharmacol 2005;507:7-13. (Pubitemid 40126834)
30. Peričić D, Švob Štrac D, Jazvinš ćak Jembrek M, Vlainić J. Allosteric uncoupling and upregulation of benzodiazepine and GABA recognition sites following chronic diazepam treatment of HEK 293 cells stably transfected with alpha1beta2gamma2S subunits of GABA(A) receptors. Naunyn Schmiedebergs Arch Pharmacol 2007;375:177-87. (Pubitemid 46525450)
31. Peričić D, Vlainić J, Švob Štrac D. Sedative and anticonvulsant effects of zolpidem in adult and aged mice. J Neural Transm 2008;115:795-802.
32. Perrault G, Morel E, Sanger DJ, Zivkovic B. Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. J Pharmacol Exp Ther 1992;263:298-303.
33. A receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity. J Pharmacol Exp Ther 1996;276:882-90.
34. A-benzodiazepine receptors produced in transfected cells. Science 1989;245:1389-92.
35. Roca DJ, Schiller GD, Friedman L, Rozenberg I, Gibbs TT, Farb DH. γ-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines. Mol Pharmacol 1990;37:710-9. (Pubitemid 20171507)
36. Sanger DJ, Morel E, Perrault G. Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem. Eur J Pharmacol 1996;313:35-42. (Pubitemid 26342203)
37. Sanna E, Busonero F, Talani G, Carta M, Massa F, Peis M, et al. Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes. Eur J Pharmacol 2002;451:103-10. (Pubitemid 35253948)
38. Shaw G, Morse S, Ararat M, Graham FL. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 2002;16:869-71.
39. Sieghart W. Structure and pharmacology of γ-aminobutyric acidA receptor subtypes. Pharmacol Rev 1995;47:181-234.
40. Švob Štrac D, Vlainić J, Jazvinšćak Jembrek M, Peričić D. Differential effects of diazepam treatment and withdrawal on recombinant GABAA receptor expression and functional coupling. Brain Res 2008;1246:29-40.
41. A receptor subunit expression by pharmacological agents. Pharmacol Rev 2010;62:97-135.
42. A receptor β2-α6-α1-γ2 subunit gene cluster. Mol Cell Neurosci 2000;16:34-41.
43. Vlainić J, Peričić D. Effect of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam. Neuropharmacology 2009;56:1124-30.
44. Vlainić J, Peričić D. Zolpidem is a potent anticonvulsant in adult and aged mice. Brain Res 2010;1310:181-8.
45. Vlainić J, Jazvinšćak Jembrek M, Švob Štrac D, Peričić D. The effects of zolpidem treatment and withdrawal on the in vitro expression of recombinant alpha1beta2gamma2s GABA(A) receptors expressed in HEK 293 cells. Naunyn Schmiedebergs Arch Pharmacol 2010;382:201-12.
46. A receptor subtypes: any clues to the mechanism of benzodiazepine dependence? Curr Opin Pharmacol 2005;5:47-52.
47. Zhu WJ, Vicini S, Harris BT, Grayson DR. NMDA-mediated modulation of gamma-aminobutyric acid type A receptor function in cerebellar granule neurons. J Neurosci 1995;15:7692-701. (Pubitemid 3010101)